Clinical trial
A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy…
NCT00432679 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00432679 |
|---|---|
| Title | A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study |
| Official title | Clinical Evaluation of Rosiglitazone Maleate (BRL49653C) in Patients With Type 2 Diabetes Mellitus (Combination Therapy With Sulfonyl Urea) - A Placebo-Controlled Double-Blind Study - |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Rosiglitazone (BRL49653C) |
| Enrollment | 149 |
| Start date | May 24, 2006 |
| Primary completion | Mar 28, 2007 |
| Completion | Mar 28, 2007 |
| First posted | Feb 8, 2007 |
| Last update posted | Dec 12, 2022 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: